These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17229911)

  • 1. Center effects in anemia management of dialysis patients.
    Fink JC; Hsu VD; Zhan M; Walker LD; Mullins CD; Jones-Burton C; Langenberg P; Seliger SL
    J Am Soc Nephrol; 2007 Feb; 18(2):646-53. PubMed ID: 17229911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy of dialysis and differences in hematocrit among dialysis facilities.
    Ifudu O; Uribarri J; Rajwani I; Vlacich V; Reydel K; Delosreyes G; Friedman EA
    Am J Kidney Dis; 2000 Dec; 36(6):1166-74. PubMed ID: 11096041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug usage evaluation of epoetin in chronic renal failure.
    Mason NA; Iacobellis DP
    Hosp Formul; 1992 Sep; 27(9):928-32, 937-8. PubMed ID: 10121421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia and survival in Thai hemodialysis patients: evidence from national registry data.
    Krairittichai U; Supaporn T; Aimpun P; Wangsiripaisan A; Chaiprasert A; Sakulsaengprapha A; Chittinandana A; Thanachartwet W; Palasawatdhi V; Srangsomwong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S242-7. PubMed ID: 17044478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients.
    Chan KE; Lafayette RA; Whittemore AS; Hlatky MA; Moran J
    Nephrol Dial Transplant; 2008 Sep; 23(9):2948-56. PubMed ID: 18469314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of IV iron in the treatment of anaemia of ESRD patients on maintenance haemodialysis: an historical and personal view.
    Shaldon S
    Nephrol Dial Transplant; 2007 Jan; 22(1):23-5. PubMed ID: 17088269
    [No Abstract]   [Full Text] [Related]  

  • 7. Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients.
    Chan K; Moran J; Hlatky M; Lafayette R
    Nephrol Dial Transplant; 2009 Jun; 24(6):1956-62. PubMed ID: 19176685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatitis C infection on anemia in hemodialysis patients.
    Khurana A; Nickel AE; Narayanan M; Foulks CJ
    Hemodial Int; 2008 Jan; 12(1):94-9. PubMed ID: 18271849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible influence of vitamin D receptor gene polymorphisms on recombinant human erythropoietin requirements in dialysis patients.
    Sezer S; Tutal E; Bilgic A; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):40-4. PubMed ID: 17275471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gulf Survey on Anemia Management (GSAM 2005).
    Alsuwaida A; Abdulkareem A; Alwakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):206-14. PubMed ID: 17496396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past, present, and future of chronic kidney disease anemia management in the United States.
    Wish JB
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):101-8. PubMed ID: 19233069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of anemia in chronic kidney disease (predialysis) patients: nephrology nursing implications.
    Wish JB; Weigel KA
    Nephrol Nurs J; 2001 Jun; 28(3):341-5. PubMed ID: 12143456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding a rational approach to ESA therapy--for payers and patients.
    Messana A
    Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and severity of anemia in pediatric hemodialysis patients.
    Azhir A; Nasiri J; Gheisari A
    Saudi Med J; 2007 Feb; 28(2):249-53. PubMed ID: 17268705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of epoetin zeta for correction of renal anemia in hemodialysis patients with thalassemia minor.
    Kumchev E; Koytchev R; Dimitrakov D; Stavrev P; Tsochev G; Siebert-Weigel M
    Adv Ther; 2008 Dec; 25(12):1375-8. PubMed ID: 19043680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected research topics.
    Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):96-104. PubMed ID: 1951363
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices.
    Liu J; Li S; Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
    Am J Kidney Dis; 2014 Oct; 64(4):608-15. PubMed ID: 24820317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.